Stock HLS HLS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart HLS Therapeutics Inc.

Equities

HLS

CA40390B1094

Market Closed - Toronto S.E.
Other stock markets
 10:37:59 2024-05-08 am EDT 		5-day change 1st Jan Change
4.78 CAD +1.06% Intraday chart for HLS Therapeutics Inc. +2.80% +21.01%
12:36pm HLS Therapeutics Brief: Q1 2024 revenue was US$12.5 million, Adjusted EBITDA was $2.7 million and cash from operations was $0.8 million MT
Apr. 08 HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Pharmaceuticals Wholesale

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
HLS THERAPEUTICS INC. Stock HLS Therapeutics Inc.
 111M - - -
MCKESSON CORPORATION Stock McKesson Corporation
 70.67B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
 23.73B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
 8.26B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
 8.07B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
 8.28B
  1. Stock Market
  2. Equities
  3. HLS Stock
  4. Charts HLS Therapeutics Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW